Go to homepage
Go to homepage
Your Cart
US$0.00

Loading...
Gastric Inhibitory Polypeptide - GIP - Glucose-Dependent Insulinotropic Polypeptide
Gastric Inhibitory Polypeptide - GIP - Glucose-Dependent Insulinotropic Polypeptide
Gastric Inhibitory Polypeptide - GIP - Glucose-Dependent Insulinotropic Polypeptide
Gastric Inhibitory Polypeptide - GIP - Glucose-Dependent Insulinotropic Polypeptide
SP-CAT-046

Gastric Inhibitory Polypeptide - GIP - Glucose-Dependent Insulinotropic Polypeptide

US$524.00

Excluding tax and shipping fees

In stock

Log in to download quote

Description

About Gastric Inhibitory Polypeptide - GIP - Glucose-Dependent Insulinotropic Polypeptide

Gastric inhibitory polypeptide (GIP), a so-called incretin, is essential for regulation of insulin secretion and glucose homeostasis. GIP is a peptide hormone consisting of 42 amino acids, is a stimulator of glucose-dependent insulin secretion and a weak inhibitor of gastric acid secretion and may have stimulate the lipoprotein lipase activity. For research use only, do not use in humans!

Gastric Inhibitory Polypeptide - GIP - Glucose-Dependent Insulinotropic Polypeptide - Specifications

  • Peptide sequence: H-YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ-OH
  • Amount: 1.0 mg net (AAA)
  • Purity: >95% (HPLC-MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in plastic vial
  • Chemical formula: C226H338N60O66S
  • MW (average): 4983.6
  • Application(s): Diabetes research
  • Condition(s)/Topic(s): Diabetes
  • Standard Delivery Time: 2-5 days
  • CAS: 100040-31-1
  • SMILES: O=C(N[C@H](C(N[C@@H](CCCCN)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC1=CNC=N1)C(N[C@H](C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](C(C)C)C(N[C@@H](CC(N)=O)C(N[C@@H](CC3=CNC4=C3C=CC=C4)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCCN)C(NCC(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](CC5=CNC6=C5C=CC=C6)C(N[C@@H](CCCCN)C(N[C@@H](CC7=CNC=N7)C(N[C@@H](CC(N)=O)C(N[C@@H]([C@H](CC)C)C(N[C@@H]([C@@H](C)O)C(N[C@@H](CCC(N)=O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CCC(N)=O)=O)=O)=O)=O)CC(O)=O)[C@H](CCSC)NC([C@H](C)NC([C@H]([C@@H](C)CC)NC([C@H](CO)NC([C@H](CC8=CC=C(O)C=C8)NC([C@H](CC(O)=O)NC([C@H](CO)NC([C@H]([C@H](CC)C)NC([C@H](CC9=CC=CC=C9)NC([C@H]([C@@H](C)O)NC(CNC([C@H](CCC(O)=O)NC([C@H](C)NC([C@H](CC%10=CC=C(O)C=C%10)N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O

Are you interested in other peptides or conjugation to a protein, nucleic acid or lipid? Choose your sequence, amount and purity with our Custom Peptide Synthesis services.

JPT’s Gastric Inhibitory Polypeptide - GIP Peptide

JPT Peptide Technologies has substantial, long-standing expertise in providing peptides in all formats, scales and modifications to the global scientific community. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Peptides

  • All peptides are made in Germany
  • Bulk orders or custom peptide synthesis upon request
  • Provision of freeze-dried aliquots for enhanced stability
  • Proven track record
  • Need the conjugated or modified peptide? Contact us!

References

References for Gastric Inhibitory Polypeptide - GIP - Glucose-Dependent Insulinotropic Polypeptide

References:
Read References with Specialty Peptides

Testimonial:
"Our group focuses on the in vitro study of risk factors in Alzheimer’s disease and, as we experienced that the in-house expression and production of the amyloid beta peptide is notoriously difficult, we are continuously dependent on a high quality supply of a large variety of these peptides from commercial source.We started our collaboration with JPT with their request to test a range of their peptides for the ability to produce toxic oligomers and fibrillar networks and were impressed by the rapid supply of a very wide range of high purity peptides with excellent fibril forming properties and toxicity profiles. JPT has shown real valuable know-how and experience in the field of peptide synthesis by their ability to generate high quality preparations of amyloid beta peptide variants which are known for their difficulty to handle."
Kerensa Broersen, Assistant Prof., Nanobiophysics Group, University of Twente, Enschede, The Netherlands

Testimonial:
Our group focuses on the in vitro study of risk factors in Alzheimer’s disease and, as we experienced that the in-house expression and production of the amyloid beta peptide is notoriously difficult, we are continuously dependent on a high quality supply of a large variety of these peptides from commercial source.We started our collaboration with JPT with their request to test a range of their peptides for the ability to produce toxic oligomers and fibrillar networks and were impressed by the rapid supply of a very wide range of high purity peptides with excellent fibril forming properties and toxicity profiles. JPT has shown real valuable know-how and experience in the field of peptide synthesis by their ability to generate high quality preparations of amyloid beta peptide variants which are known for their difficulty to handle.
Kerensa Broersen, Assistant Prof., Nanobiophysics Group, University of Twente, Enschede, The Netherlands

Documentation

Documentation for Gastric Inhibitory Polypeptide - GIP - Glucose-Dependent Insulinotropic Polypeptide


Properties

Properties of Gastric Inhibitory Polypeptide - GIP - Glucose-Dependent Insulinotropic Polypeptide

Properties Values
Amount: 1.0 mg net (AAA)
Application: Diabetes research
Category: Diabetes Peptides
Condition / Topic: Diabetes
Layout: Freeze-dried in plastic vial
Organism: Human
Protein Name: Diabetes Peptide
Purity: >95% (HPLC-MS)
Quantification: Yes

Further Information to Gastric Inhibitory Polypeptide - GIP - Glucose-Dependent Insulinotropic Polypeptide

Information Values
Sequence: H-YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ-OH
Loading...

Check our list of products, click and go.

Get a quote